HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrew D Goodman Selected Research

ibudilast

11/2021Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis.
1/2021Optical coherence tomography outcomes from SPRINT-MS, a multicenter, randomized, double-blind trial of ibudilast in progressive multiple sclerosis.
1/2021Response to ibudilast treatment according to progressive multiple sclerosis disease phenotype.
1/2021Effects of Ibudilast on MRI Measures in the Phase 2 SPRINT-MS Study.
10/2016Ibudilast for the treatment of multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrew D Goodman Research Topics

Disease

19Multiple Sclerosis
10/2022 - 05/2003
3Atrophy
01/2021 - 01/2021
2Disease Progression
01/2022 - 07/2014
2Relapsing-Remitting Multiple Sclerosis
11/2014 - 04/2014
2Fatigue
10/2003 - 03/2002
1Ganglion Cysts (Ganglion)
01/2021
1Bradycardia
12/2019
1Chronic Disease (Chronic Diseases)
04/2016
1Pain (Aches)
04/2016
1Progressive Multifocal Leukoencephalopathy
09/2010
1Optic Neuritis (Retrobulbar Neuritis)
04/2008
1Transverse Myelitis (Necrotizing Myelitis)
04/2008

Drug/Important Bio-Agent (IBA)

5ibudilastIBA
11/2021 - 10/2016
54-Aminopyridine (4 Aminopyridine)FDA Link
12/2015 - 10/2010
3TabletsIBA
12/2015 - 01/2014
2Amantadine (Aman)FDA LinkGeneric
01/2022 - 03/2002
2Biomarkers (Surrogate Marker)IBA
11/2021 - 07/2014
2Natalizumab (Tysabri)FDA Link
11/2014 - 09/2010
1Glatiramer Acetate (Copaxone)FDA Link
10/2022
1siponimodIBA
12/2019
1Interferon beta-1aFDA Link
11/2014
1Neutralizing AntibodiesIBA
04/2014
1AntibodiesIBA
04/2014
1InterferonsIBA
04/2014
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2013
1DNA (Deoxyribonucleic Acid)IBA
09/2010
1Memantine (Namenda)FDA Link
02/2010
1Immunoglobulin G (IgG)IBA
04/2008
1AntigensIBA
05/2003
1Pemoline (Cylert)FDA Link
03/2002

Therapy/Procedure

3Therapeutics
04/2016 - 03/2002
1Aftercare (After-Treatment)
01/2022
1Immunomodulation
05/2011
1Immunotherapy
04/2008